For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240730:nBw2mpQz2a&default-theme=true
Form 8.3 - QUANEX BUILDING PRODUCTS CORPORATION
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Qube Research & Technologies Limited
(b) Owner or controller of interests and short positions disclosed, if
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form Quanex Building Products Corporation
relates:
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state this
and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: 29-07-2024
For an opening position disclosure, state the latest practicable date prior to
the disclosure
(f) In addition to the company in 1(c) above, is the discloser making Yes - Tyman PLC
disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state “N/A”
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
(a) Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: Common Stock
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 84,141 0.25 0 0.0
(2) Cash-settled derivatives: 0 0.0 0 0.0
(3) Stock-settled derivatives (including options) and agreements to 0 0 0 0
purchase/sell:
84,141 0.25 0 0.0
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors’ and other
employee options)
Class of relevant security in relation to which subscription right exists: 0
Details, including nature of the rights concerned and relevant percentages: 0
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit (USD)
Common Stock Sale 30 34.29
Common Stock Sale 100 34.15
Common Stock Sale 100 34.27
Common Stock Sale 100 34.30
Common Stock Sale 100 34.41
Common Stock Sale 100 34.46
Common Stock Sale 100 34.55
Common Stock Sale 100 34.56
Common Stock Sale 100 34.59
Common Stock Sale 100 34.61
Common Stock Sale 100 34.63
Common Stock Sale 100 34.66
Common Stock Sale 100 34.69
Common Stock Sale 100 34.72
Common Stock Sale 100 34.73
Common Stock Sale 100 34.76
Common Stock Sale 112 34.44
Common Stock Sale 141 34.65
Common Stock Sale 200 34.19
Common Stock Sale 200 34.24
Common Stock Sale 200 34.37
Common Stock Sale 200 34.47
Common Stock Sale 200 34.56
Common Stock Sale 200 34.58
Common Stock Sale 200 34.71
Common Stock Sale 200 34.79
Common Stock Sale 200 34.86
Common Stock Sale 200 34.91
Common Stock Sale 211 34.43
Common Stock Sale 283 34.72
Common Stock Sale 292 34.78
Common Stock Sale 300 34.16
Common Stock Sale 300 34.33
Common Stock Sale 300 34.57
Common Stock Sale 300 34.59
Common Stock Sale 300 34.62
Common Stock Sale 300 34.67
Common Stock Sale 300 34.74
Common Stock Sale 317 34.55
Common Stock Sale 342 34.45
Common Stock Sale 388 34.42
Common Stock Sale 400 34.17
Common Stock Sale 400 34.18
Common Stock Sale 400 34.49
Common Stock Sale 400 34.54
Common Stock Sale 400 34.54
Common Stock Sale 402 34.70
Common Stock Sale 426 34.63
Common Stock Sale 426 34.76
Common Stock Sale 452 34.77
Common Stock Sale 500 34.27
Common Stock Sale 500 34.31
Common Stock Sale 500 34.48
Common Stock Sale 500 34.75
Common Stock Sale 542 34.51
Common Stock Sale 550 34.29
Common Stock Sale 561 34.30
Common Stock Sale 594 34.69
Common Stock Sale 600 34.40
Common Stock Sale 603 34.61
Common Stock Sale 616 34.31
Common Stock Sale 620 34.38
Common Stock Sale 629 34.23
Common Stock Sale 632 34.27
Common Stock Sale 638 34.37
Common Stock Sale 678 34.53
Common Stock Sale 700 34.39
Common Stock Sale 710 34.36
Common Stock Sale 784 34.47
Common Stock Sale 800 34.33
Common Stock Sale 834 34.50
Common Stock Sale 884 34.32
Common Stock Sale 900 34.20
Common Stock Sale 900 34.22
Common Stock Sale 900 34.34
Common Stock Sale 900 34.60
Common Stock Sale 985 34.35
Common Stock Sale 997 34.26
Common Stock Sale 1000 34.52
Common Stock Sale 1098 34.64
Common Stock Sale 1100 34.21
Common Stock Sale 1151 34.25
Common Stock Sale 6837 34.28
Common Stock Purchase 22 34.61
Common Stock Purchase 43 34.20
Common Stock Purchase 78 34.65
Common Stock Purchase 100 34.77
Common Stock Purchase 264 34.05
Common Stock Purchase 4628 34.28
(b) Cash-settled derivative transactions
Class of relevant security Product description Nature of dealing Number of securities Exercise price per unit (USD)
e.g. call option
e.g. opening/closing a long/short position, increasing/reducing a long/short
position
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (USD) Type Expiry date Option money paid/ received per unit
e.g. American, European etc.
(ii) Exercise
Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit
e.g. call option
0 0 0 0
0
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
0 0 0
0
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may
be an inducement to deal or refrain from dealing entered into by the person
making the disclosure and any party to the offer or any person acting in
concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there
are no such agreements, arrangements or understandings, state “none”
None
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state
“none”
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 30-07-2024
Contact name: Stuart Brown
Telephone number: 00442070722969
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.
The Panel’s Market Surveillance Unit is available for consultation in
relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The
Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk
(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54101624&newsitemid=20240730517675&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=24c3dc6f80668ad010262ba338e19ce3)
.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20240730517675/en/
(https://www.businesswire.com/news/home/20240730517675/en/)
Qube Research & Technologies LTD
Copyright Business Wire 2024